Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 10, 2011, Pages 2356-2363

  Mcintyre, Natasha J ^a   Fluck, Richard J ^a   Mcintyre, Christopher W ^a,b   Taal, Maarten W ^a  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; BICARBONATE; C REACTIVE PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; AUTOFLUORESCENCE; BICARBONATE BLOOD LEVEL; BIOCHEMISTRY; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE WAVE; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; SKIN AUTOFLUORESCENCE; SKIN EXAMINATION; SMOKING; TISSUE DISTRIBUTION; URIC ACID BLOOD LEVEL; URINALYSIS; WAIST HIP RATIO;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DISEASE PROGRESSION; ENGLAND; FEMALE; FLUORESCENCE; FOREARM; GLOMERULAR FILTRATION RATE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SKIN; UP-REGULATION;

EID: 80053917468     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02420311     Document Type: Article

References (48)

1. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56: 2214-2219, 1999
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
3. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ: Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16: 3687-3693, 2005
4. Rucker D, Tonelli M: Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol 5: 287-296, 2009
5. Noordzij MJ, Lefrandt JD, Smit AJ: Advanced glycation end products in renal failure: An overview. J Ren Care 34: 207-212, 2008
6. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991
7. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Valssara H: Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci 1043: 461-466, 2005
8. Treweek JB, Dickerson TJ, Janda KD: Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology. Acc Chem Res 42: 659-669, 2009
9. Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmenn K, Vlassara H: Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 94: 6474-6479, 1997
10. Thornalley PJ, Rabbani K: Highlights and hotspots of protein glycation in end-stage renal disease. Semin Dial 22: 400-404, 2009
11. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele DS: Implication of an increased oxidative stress in the formation of advanced glycation endproducts in patients with end-stage renal failure. Kidney Int 51: 1170-1181, 1997
12. Baynes JW: From life to death-the struggle between chemistry and biology during aging: The Maillard reaction as an amplifier of genomic damage. Biogerontology 1: 235-246, 2000
13. Smit AJ, Gerrits EG: Skin autofluorescence as a measure of advanced glycation endproduct deposition: A novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens 19: 527-533, 2010
14. Linden E, Cai W, He JC, Hue C, Li Z, Winson J, Vlassara H, Uribarri J: Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 3: 691-698, 2008
15. D'Agati V, Schmidt AM: RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol 6: 352-360, 2010
16. Lindsey JB, Cipollone F, Abdullah SM, McGuire DK: Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): Cardiovascular implications. Diab Vasc Dis Res 6: 7-14, 2009
17. Ueno H, Koyama H, Tanaka S, Fukumoto S, Shinohara K, Shoji T, Emoto M, Tahara H, Kakiya R, Tabata T, Miyata T, Nishizawa Y: Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 57: 1452-1457, 2008
18. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM: Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 63: 1852-1860, 2003
19. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jagar JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47: 1324-1330, 2004
20. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR: Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 314: 403-408, 1986
21. Hartog JW, Hummel YM, Voors AA, Schalkwijk CG, Miyata T, Huisman RM, Smit AJ, Van Veldhuisen DJ: Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients. J Card Fail 14: 596-602, 2008
22. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ: Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30: 107-112, 2007
23. Lutgers HL, Gerrits EG, Graaff R, Lins TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ: Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 52: 789-797, 2009
24. Ueno H, Koyama H, Fukumoto S, Tanaka S, Shoji T, Emoto M, Tahara H, Inaba M, Kakiya R, Tabata T, Miyata T, Nishizawa Y: Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease. Metabolism 60: 453-459, 2010
25. Noordzij MJ, Lefrandt JD, Loeffen EA, Saleem BR, Meerwaldt R, Lutgers HL, Smit AJ, Zeebregts CJ: Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease. Int J Cardiovasc Imaging, ePub ahead of print, 2011
26. Bos DC, de Ranitz-Greven WL, de Valk HW: Advanced glycation end products, measured as skin autofluorescence and diabetes complications: A systematic review. Diabetes Technol Ther, ePub ahead of print, April 21, 2011
27. Hartog JW, de Vries AP, Bakker SJ, Graaff R, van Son WJ, van der Heide JJ, Gans RO, Wolffenbuttel BH, de Jong PE, Smit AJ: Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients. Nephrol Dial Transplant 21: 2263-2269, 2006
28. McIntyre NJ, Chesterton LJ, John SG, Jefferies HJ, Burton JO, Taal MW, Fluck RJ, McIntyre CW: Tissue-advanced glycation end product concentration in dialysis patients. lin J Am Soc Nephrol 5: 51-55, 2010
29. Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, Hayashi Y, Asahi K, Katoh T, Miyata, Watanabe T: Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients. Nephrol Dial Transplant ePub ahead of print. 2010
30. The National Institute for Health and Clincal Excellence. Chronic kidney disease: National clinical guideline for early identification and management in adults in primary and secondary care. Available online at http://www.nice.org.uk/nicemedia/pdf/CG073NICEGuideline.pdf. 2008
31. Jordan H, Roderick P, Martin D: The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health 58: 250-257, 2004
32. The Office of National Statistics. Available at http:/www.neighbourhood.statistics.gov.uk/dissemination? Info.do? age_news/newsitems/7-december-2007-indicies-ofdeprivation-2007.htm.
33. The World Health Organization and International Diabetes Federation: The Definition and Diagnosis of Diabetes Mellitus and Intermedicate Glycaemia, WHO Press, 2006
34. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE, on behalf of the PREVEND study group: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41: 733-741, 2003
35. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Masterson BJ, Oparil S, Wright JT Jr, Rocella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. J Am Med Assoc 289: 2560-2572, 2003
36. Hickson SS, Butlin M, Broad J, Avolio AP, Wilkinson IB, McEniery CM: Validity and repeatability of the Vicorder apparatus: A comparison with the SphygmoCor device. Hypertens Res 32: 1079-1085, 2009
37. Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ: Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther 13: 165-170, 2011
38. Koetsier M, Lutgers HL, de Jong C, Links TP, Smit AJ, Graaff R: Reference values of skin autofluorescence. Diabetes Technol Ther 12: 399-403, 2010
39. Thomas MC, Tsalamandris C, Maclsaac R, Medley T, Kingwell B, Cooper ME, Jerums G: Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int 66: 1167-1172, 2004
40. Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Hoir O, Zoukourian C, Capron L, Chappey O, Yan SD, Brett J, et al: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A 91: 7742-7746, 1994
41. Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25, 2006
42. Ando K, Beppu M, Kikugawa K, Nagai R, Horiuchi S: Membrane proteins of human erythrocytes are modified by advanced glycation end products during aging in the circulation. Biochem Biophys Res Commun 258: 123-127, 1999
43. Iwata H, Ukeda H, Maruyama T, Fujino T, Sawamura M: Effect of carbonyl compounds on red blood cells deformability. Biochem Biophys Res Commun 321: 700-706, 2004
44. Monnier VM, Kohn RR, Cerami A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A 81: 583-587, 1984
45. Na R, Stender IM, Henrikson M, Wulf HC: Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 116: 536-540, 2001
46. Stamatas GN, Estanislao RB, Suero M, Rivera ZS, Li J, Khaiat A, Kollias N: Facial skin fluorescence as a marker of the skin's response to chronic environmental insults and its dependence on age. Br J Dermatol 154: 125-132, 2006
47. Gerrits EG, Smit AJ, Bilo HJ: AGEs, autofluorescence and renal function. Nephrol Dial Transplant 24: 710-713, 2009
48. Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, Morley AL, Thallas-Bonke V, Chand V, Penfold SA, de Couten MP, Thomas MC, Kingwell BA, Bierhaus A, Cooper ME, Courten BD, Forbes JM: Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int, ePub ahead of print, March 16, 2011